Quantcast
Last updated on April 21, 2014 at 7:52 EDT

Latest Philip Low Stories

2014-03-16 23:00:43

Purdue University and Houston Methodist Research Institute plan to collaborate on research and educational initiatives, including clinical trials of drugs developed at Purdue. West Lafayette, IN (PRWEB) March 16, 2014 Purdue University and Houston Methodist Research Institute plan to collaborate on research and educational initiatives, including clinical trials of drugs developed at Purdue. The partnership helps to advance the Purdue Moves drug discovery initiative to translate basic...

2013-10-17 16:25:07

Announcement follows Congressman Fattah's meeting with NeuroVigil CEO, Dr. Philip Low WASHINGTON, Oct. 17, 2013 /PRNewswire-USNewswire/ -- A new technology that will enable patients suffering from ALS --commonly known as Lou Gehrig's Disease--to communicate via brain monitor, will hold its first clinical trials in Philadelphia. Congressman Chaka Fattah (PA-02) was on hand for the announcement, made Tuesday at the BrainTech Israel conference in Tel Aviv. The announcement came...

iBrain Could Soon Help Stephen Hawking Communicate
2012-07-08 08:54:14

redOrbit Staff & Wire Reports - Your Universe Online An American scientist currently developing a device that would allow Professor Stephen Hawking to "write" words with his brain waves is scheduled to present his latest findings at a consciousness conference in the UK city of Cambridge, BBC News and Asian News International reported on Saturday. As previously reported by our own Lee Rannals, the device in question is known as the iBrain and is essentially a brain scanner which...

iBrain Reads Thoughts Of Stephen Hawking To Help Him Speak
2012-04-05 06:41:09

Researchers working to help renowned physicist Stephen Hawking communicate more effectively are using an experimental device dubbed the iBrain, which can read his mind. The gadget resembles a black headband, and is designed to help Hawking, who has long suffered with Lou Gehrig´s disease, communicate by merely thinking. The research is being led by Philip Low, a 32-year-old neuroscientist and CEO of NeuroVigil, who hopes the new device will help the 70-year-old physicist to...

2011-09-19 07:49:02

The first fluorescence-guided surgery on an ovarian cancer patient was performed using a cancer cell "homing device" and imaging agent created by a Purdue University researcher. The surgery was one of 10 performed as part of the first phase of a clinical trial to evaluate a new technology to aid surgeons in the removal of malignant tissue from ovarian cancer patients. The method illuminates cancer cells to help surgeons identify and remove smaller tumors that could otherwise be missed....

2009-07-13 13:47:08

U.S. scientists say they have developed a prostate cancer homing device that could improve detection and allow the first targeted treatment of the disease. Purdue University researchers said they synthesized a molecule that finds and penetrates prostate cancer cells, and have created imaging agents and therapeutic drugs that can link to the molecule and be carried with it as cargo. Professor Philip Low, who led the research, said a targeted treatment could be much more effective in treating...

a2d028bdcb5c719cc04a98a16dacc6551
2009-07-06 14:45:00

A new prostate cancer "homing device" could improve detection and allow for the first targeted treatment of the disease.A team of Purdue University researchers has synthesized a molecule that finds and penetrates prostate cancer cells and has created imaging agents and therapeutic drugs that can link to the molecule and be carried with it as cargo.A radioimaging application used for body scans is expected to enter clinical trials this fall, and an optical imaging application used to measure...